TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/29/21 13:38 | 3/26/21 | CRDF | Cardiff Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | P | 30 | 10.32 | 0 | 3 | 10 | 31 | I | |||||||||||||||
5/18/20 16:16 | 5/14/20 | CRDF | Cardiff Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | P | 30 | 1.43 | 0 | 21 | 292 | 28 | I | |||||||||||||||
11/9/18 16:30 | 6/20/18 | TROV | Trovagene, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | P.a | 35 | 0.8500 | 0 | 41 | 999% | 43 | D | |||||||||||||||
6/21/18 16:30 | 6/20/18 | TROV | Trovagene, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | P | 35 | 0.8500 | 0 | 41 | 182 | 64 | D | |||||||||||||||
1/4/18 17:15 | 1/2/18 | TROV | Trovagene, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | M.d | 0 | 0.00 | 0 | 17 | 280 | 23 | D | |||||||||||||||
9/6/17 20:40 | 9/2/17 | TROV | Trovagene, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Markin Rodney S | CA | D | M.d | 0 | 0.00 | 0 | 6 | New | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |